内镜后上消化道癌症相关的临床与内镜特征:系统综述与Meta分析
该系统综述与Meta分析检索MEDLINE和Embase,纳入25项研究共81,184例上消化道癌症(其中7,926例为内镜后上消化道癌症),比较内镜后癌症与检出癌症的特征。内镜后癌症诊断间隔平均约17个月,报警症状较少,分期较早,多数在先前「癌症阴性」内镜时已有异常发现。
要点
- 内镜后上消化道癌症诊断延迟平均约17个月
- 内镜后癌症较检出癌症更少表现为吞咽困难和体重减轻
- 多数内镜后癌症在先前「癌症阴性」内镜时已有异常报告
核心结论
- 内镜后上消化道癌症诊断存在明显延迟,报警症状较少,诊断时分期较早,多数先前内镜已有异常报告,其流行病学特征可为预防策略提供信息。
研究设计与样本
- 系统综述与Meta分析,检索MEDLINE和Embase自建库起,纳入25项比较内镜后上消化道癌症与检出上消化道癌症特征的研究,共81,184例上消化道癌症,其中7,926例为内镜后上消化道癌症,采用随机效应Meta分析,PROSPERO注册号CRD42019125780。
主要发现
- 在「癌症阴性」内镜后6至36个月内评估的内镜后上消化道癌症,平均间隔约17个月。
- 内镜后上消化道癌症患者较检出癌症患者更少表现为吞咽困难(OR 0.37)和体重减轻(OR 0.58),更常表现为胃食管反流(OR 2.64)。
- 在西方人群中,内镜后上消化道癌症更常见于女性(OR 1.30)。
- 内镜后上消化道癌症诊断时通常较小,且分期较检出癌症更早(1期 vs 2-4期 OR 2.87)。
- 大多数(>75%)内镜后上消化道癌症诊断前内镜异常。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Ten percent of patients with an upper gastrointestinal cancer will have received an esophagogastroduodenoscopy (EGD) within 3 years before diagnosis, termed post-endoscopy upper gastrointestinal cancers (PEUGIC). We aimed to determine the characteristics of PEUGIC, and compare these with detected cancers. METHODS: We searched MEDLINE and Embase from inception for studies comparing the characteristics of PEUGIC and detected upper gastrointestinal cancers, and reported findings at the initial "cancer-negative" endoscopy. We synthesized results using random effects meta-analysis. This review is registered on PROSPERO, CRD42019125780. RESULTS: A total of 2696 citations were screened and 25 studies were included, comprising 81,184 UGI cancers, of which 7926 were considered PEUGIC. For PEUGIC assessed within 6 to 36 months of a "cancer-negative" EGD, the mean interval was approximately 17 months. Patients with PEUGIC were less likely to present with dysphagia (odds ratio [OR] 0.37) and weight loss (OR 0.58) and were more likely to present with gastroesophageal reflux (OR 2.64) than detected cancers. PEUGICs were more common in women in Western populations (OR 1.30). PEUGICs were typically smaller at diagnosis and associated with less advanced disease staging compared with detected cancers (OR 2.87 for stage 1 vs 2-4). Most EGDs (>75%) were abnormal preceding diagnosis of PEUGIC. CONCLUSIONS: There is a substantial delay in the diagnosis of PEUGIC. They are less likely to present with alarm symptoms than detected cancers. PEUGICs are overall less advanced at diagnosis. Most patients with PEUGIC have abnormalities reported at the preceding "cancer-negative" EGD. The epidemiology of PEUGIC may inform preventive strategy.
引用
- Alexandre L, Tsilegeridis-Legeris T, Lam S, et al. Clinical and Endoscopic Characteristics Associated With Post-Endoscopy Upper Gastrointestinal Cancers: A Systematic Review and Meta-analysis. Gastroenterology. 2021. PMID: 34958760. doi:10.1053/j.gastro.2021.12.270
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。